(NTLA) Intellia Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Intellia Therapeutics | (NTLA) share price targets
Complete technical analysis of Intellia Therapeutics (NTLA) by charts plus indicators, forecast predictions and share price targets for Intellia Therapeutics (NTLA)
Intellia Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-11 View latest technical analysis
10 day averaged volume of Intellia Therapeutics is 2485140
| Date | Daily Closing Price | Open | High | Low | Volume |
| 11 Tue Feb 2025 | 9.21 | 9.39 | 9.48 | 9.08 | 0.869 times |
| 10 Mon Feb 2025 | 9.58 | 9.92 | 9.97 | 9.47 | 0.806 times |
| 07 Fri Feb 2025 | 9.79 | 10.07 | 10.43 | 9.72 | 0.829 times |
| 06 Thu Feb 2025 | 10.13 | 10.63 | 10.73 | 10.07 | 1.039 times |
| 05 Wed Feb 2025 | 10.51 | 9.76 | 10.63 | 9.72 | 1.057 times |
| 04 Tue Feb 2025 | 9.62 | 9.55 | 9.79 | 9.41 | 0.997 times |
| 03 Mon Feb 2025 | 9.54 | 9.79 | 9.90 | 9.32 | 1.24 times |
| 31 Fri Jan 2025 | 10.32 | 10.58 | 10.65 | 10.11 | 0.87 times |
| 30 Thu Jan 2025 | 10.51 | 10.32 | 10.73 | 10.10 | 0.876 times |
| 29 Wed Jan 2025 | 10.12 | 9.97 | 10.42 | 9.93 | 1.021 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 9.5, but if it comes above 9.5, then a intra day buy could be more profitable.
If you take a sell trade below 9.5, then use 9.5 as stoploss and 8.8 as target. However if you take a buy trade in stock , then use 9.5 as stoploss and 10.06 as target.
Share price targets for Intellia Therapeutics (NTLA)
| Target Type | Value |
| Downside Target | 9.08 |
| Upside Target | 9.55 |
| Upside Target | 9.93 |
| Upside Target | 10.73 |
| Upside Target | 11.34 |
| Upside Target | 11.46 |
| Upside Target | 12.82 |
| Upside Target | 13.34 |
| Upside Target | 13.95 |
| Upside Target | 15.29 |
| Upside Target | 17.83 |
| Upside Target | 21.47 |
Intraday share price targets for Intellia Therapeutics (NTLA)
| Target Type | Value |
| Downside Intraday Target | 8.87 |
| Downside Intraday Target | 8.53 |
| Upside Intraday Target | 9.76 |
| Upside Intraday Target | 10.31 |
| Upside Intraday Target | 9.42 |
Weekly technical analysis of Intellia Therapeutics (NTLA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 11 Tue Feb 2025 | 9.21 | 9.92 | 9.97 | 9.08 | 0.325 times |
| 07 Fri Feb 2025 | 9.79 | 9.79 | 10.73 | 9.32 | 1.01 times |
| 31 Fri Jan 2025 | 10.32 | 10.29 | 10.77 | 9.93 | 0.963 times |
| 24 Fri Jan 2025 | 10.99 | 9.60 | 11.46 | 9.55 | 3.956 times |
| 17 Fri Jan 2025 | 9.50 | 9.48 | 9.69 | 9.32 | 0.192 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Intellia Therapeutics (NTLA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 11 Tue Feb 2025 | 9.21 | 9.79 | 10.73 | 9.08 | 0.249 times |
| 31 Fri Jan 2025 | 10.32 | 11.88 | 13.34 | 9.25 | 1.869 times |
| 31 Tue Dec 2024 | 11.66 | 14.90 | 15.29 | 11.34 | 0.648 times |
| 26 Tue Nov 2024 | 14.73 | 14.21 | 17.83 | 12.82 | 0.92 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Intellia Therapeutics (NTLA)
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.
Intellia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.93 and Intellia Therapeutics (NTLA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.
Intellia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.93 and Intellia Therapeutics (NTLA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.